M. Kathleen Behrens - Mar 6, 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for M. Kathleen Behrens
Stock symbol: SRPT
Transactions as of: Mar 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/8/2023, 07:00 PM
Previous filing: Jan 4, 2023
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Award	$0	+1.52K	+0.96%	$0.00	160K	Mar 6, 2023	Direct	F1
holding	SRPT	Common Stock						10K	Mar 6, 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Award	$0	+3.26K		$0.00	3.26K	Mar 6, 2023	Common Stock	3.26K	$155.99	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024.